A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

N-Desalkyl Quetiapine Sulfoxide Impurity | CAS 1141717-54-5 - 请求报价

media.product.imagealternatetextformat.details

N-Desalkyl Quetiapine Sulfoxide Impurity

SZ目录编号:SZ-Q001090
CAS 号
1141717-54-5
分子式
C17H17N3OS
分子量
311.4
投资状态
Synthesis on demand

化学名称 :

运输温度 :

HSN编码 :

原产国 :

微笑 :

CHNS 比例 (%) :

使用说明:

N-Desalkyl Quetiapine Sulfoxide Impurity is chemically 11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine 5-oxide. N-Desalkyl Quetiapine Sulfoxide Impurity is supplied with detailed characterization data compliant with regulatory guideline. N-Desalkyl Quetiapine Sulfoxide Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Quetiapine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

应用与法规使用场景

购买 1141717-54-5

采购 1141717-54-5

订购 1141717-54-5

询问 1141717-54-5

price of 1141717-54-5

1141717-54-5 供应商

1141717-54-5 制造商

1141717-54-5 出口商

buy high quality N-Desalkyl Quetiapine Sulfoxide Impurity

采购 N-Desalkyl Quetiapine Sulfoxide Impurity

N-Desalkyl Quetiapine Sulfoxide Impurity 供应商

N-Desalkyl Quetiapine Sulfoxide Impurity 制造商

N-Desalkyl Quetiapine Sulfoxide Impurity 价格

订购 N-Desalkyl Quetiapine Sulfoxide Impurity

询问 N-Desalkyl Quetiapine Sulfoxide Impurity

N-Desalkyl Quetiapine Sulfoxide Impurity 成本

N-Desalkyl Quetiapine Sulfoxide Impurity 供应商

N-Desalkyl Quetiapine Sulfoxide Impurity 分销商

N-Desalkyl Quetiapine Sulfoxide Impurity 用于方法验证

Quetiapine 对照标准

N-Desalkyl Quetiapine Sulfoxide Impurity 用于ANDA申报

N-Desalkyl Quetiapine Sulfoxide Impurity 用于强制降解研究

N-Desalkyl Quetiapine Sulfoxide Impurity 鉴别标准

N-Desalkyl Quetiapine Sulfoxide Impurity 用于DMF申报

ℹ️

免责声明

SynZeal 在本网站上提供的产品信息是根据发布时的现有理解而提供的。客户在实际购买时有责任评估信息的准确性。

SynZeal 将根据产品规格的新发展或新发现更新这些详细信息,恕不另行通知。